Daniela Galimberti – författare
Visar alla böcker från författaren Daniela Galimberti. Handla med fri frakt och snabb leverans.
4 produkter
4 produkter
Häftad, Engelska, 2016
1 333 kr
Skickas inom 10-15 vardagar
This book gives an overview of the current knowledge on the most common neurodegenerative diseases, including Alzheimer’s disease, frontotemporal lobar degeneration, amyotrophic lateral sclerosis, and additional neurodegenerative diseases. Different aspects of each disease are reviewed, including clinical issues, treatments, basic discoveries (genetics and molecular biology), and translation of basic research into biomarkers for early diagnosis. In addition, emerging data indicate that neurodegeneration seems to also be present in classically non-degenerative disorders. Therefore, a chapter about overlapping mechanisms between dementias and psychiatric disorders is included, as well as a description of the role of neurodegeneration in multiple sclerosis.Neurodegenerative Diseases is aimed at clinicians, particularly those working in academic hospitals. This multidisciplinary book will also be of interest to basic researchers in medical fields.
Häftad, Engelska, 2025
2 305 kr
Skickas
Alzheimer’s disease (AD) is the most common form of dementia in older adults, and although significant efforts have been made to find the mechanisms and biomarkers which would enable early detection and treatment, the disease remains a major scientific and clinical challenge. A number of therapeutic interventions have been developed to target the pathology believed to play a role in the course of the disease, with varying success, and this book, Therapeutic Trials in Alzheimer’s Disease: Where Are We Now?, explores past and present clinical trials in AD based on pharmacological and non-pharmacological strategies. The book is divided into 6 parts. Part 1 focuses on pharmacological strategies aimed at the two proteins associated with AD, amyloid-β and tau; Part 2 discusses a broad range of therapeutic strategies, including metal-targeting agents and antioxidants. Part 3 deals with repurposed drugs, particularly antidiabetics and lipid-lowering therapies, and in Part 4, the challenges, advances, and therapeutic effects of stem cell and gene therapies for AD are detailed and discussed. Part 5 debates the therapeutic effects of non-pharmacological approaches, particularly ketogenic diets and supplements, as well as the benefits of physical exercise, yoga, and acupuncture. Finally, part 6 discusses the benefits of brain stimulation, and the usefulness of imaging techniques, and their ability to assess responses to treatment. Providing an overview of efforts to date in the attempt to address AD, the book will be of interest to all those involved in the research and treatment of Alzheimer’s disease.
Häftad, Engelska, 2019
1 333 kr
Skickas inom 10-15 vardagar
This book gives an overview of the current knowledge on the most common neurodegenerative diseases, including Alzheimer’s disease, frontotemporal lobar degeneration, Lewy body dementia,Parkinson’s disease, amyotrophic lateral sclerosis, and additional less common neurodegenerative diseases.
Inbunden, Engelska, 2018
1 872 kr
Skickas inom 10-15 vardagar
This book gives an overview of the current knowledge on the most common neurodegenerative diseases, including Alzheimer’s disease, frontotemporal lobar degeneration, Lewy body dementia,Parkinson’s disease, amyotrophic lateral sclerosis, and additional less common neurodegenerative diseases. Both clinical and basic aspects of each disease are treated, including novel diagnostic criteria, old and new treatments, basic discoveries (genetics, epigenetics and molecular biology), and translation of basic research into biomarkers for early diagnosis, particularly to identify peripheral biomarkers. In addition, emerging data indicate that neurodegeneration seems to also be present in classically non-degenerative disorders. Therefore, a chapter about overlapping mechanisms between dementias and psychiatric disorders is included, as well as a description of the role of neurodegeneration in multiple sclerosis.Neurodegenerative Diseases is aimed at clinicians, particularly those workingin academic hospitals. This multidisciplinary book will also be of interest to basic researchers in medical fields.